Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Open Label, Multicenter Study for the Assessment of Myocardial Perfusion Using Positron Emission Tomography (PET) Imaging of Flurpiridaz F18 Injection in Patients With Suspected or Known Coronary Artery Disease (CAD)

Next Previous
X
Search
Trial Profile

A Phase 3, Open Label, Multicenter Study for the Assessment of Myocardial Perfusion Using Positron Emission Tomography (PET) Imaging of Flurpiridaz F18 Injection in Patients With Suspected or Known Coronary Artery Disease (CAD)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 25 Nov 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fluorine 18 flurpiridaz (Primary)
  • Indications Coronary artery disease
  • Focus Diagnostic use; Registrational
  • Sponsors Lantheus Medical Imaging

    • Most Recent Events

    • 02 Nov 2015 According to a Lantheus Medical Imaging media release, data from a sub-analysis focused on the female sub-population from this study will be presented at the American Heart Association 2015 Scientific Sessions.
    • 04 May 2015 Based on the results of this trial, Lantheus redesigned the protocol for its second phase III study, including different primary endpoints, according to a media release.
    • 04 May 2015 Primary endpoint (Non-inferiority in diagnostic specificity) has not been met, according to a Lantheus Medical Imaging media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top